435 related articles for article (PubMed ID: 18648137)
1. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
[TBL] [Abstract][Full Text] [Related]
2. Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine model.
Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
Endoscopy; 2008 Jun; 40(6):506-12. PubMed ID: 18478511
[TBL] [Abstract][Full Text] [Related]
3. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
4. What are the predictors of post-ERCP pancreatitis, and how useful are they?
Sultan S; Baillie J
JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil activation and hyperamylasaemia after endoscopic retrograde cholangiopancreatography: potential role for the leukocyte in the pathogenesis of acute pancreatitis.
Mann DV; Kalu P; Foulds S; Edwards R; Glazer G
Endoscopy; 2001 May; 33(5):448-53. PubMed ID: 11396766
[TBL] [Abstract][Full Text] [Related]
6. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.
Hackert T; Werner J; Gebhard MM; Klar E
Surgery; 2004 Feb; 135(2):131-8. PubMed ID: 14739847
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of non-ionic and ionic contrast agents on pancreatic histology in a canine model.
Pfau PR; Mosley RG; Said A; Gopal DV; Fischer MC; Oberley T; Weiss J; Lee FT; Eckoff D; Reichelderfer M
JOP; 2006 Jan; 7(1):27-33. PubMed ID: 16407615
[TBL] [Abstract][Full Text] [Related]
8. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
9. Effects of thalidomide in experimental models of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Xiong GS; Wu SM; Wang ZH; Mo JZ; Xiao SD
J Gastroenterol Hepatol; 2007 Mar; 22(3):371-6. PubMed ID: 17295769
[TBL] [Abstract][Full Text] [Related]
10. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Centorrino T; Siriwardena AK; Cuzzocrea S
Shock; 2007 May; 27(5):542-51. PubMed ID: 17438460
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
12. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
Gottlieb K; Sherman S; Pezzi J; Esber E; Lehman GA
Am J Gastroenterol; 1996 Aug; 91(8):1553-7. PubMed ID: 8759660
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
Kapetanos D; Kokozidis G; Christodoulou D; Mistakidis K; Sigounas D; Dimakopoulos K; Kitis G; Tsianos EV
Gastrointest Endosc; 2007 Sep; 66(3):513-8. PubMed ID: 17725940
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ERCP- and endoscopic sphincterotomy-induced pancreatic damage: a prospective study on the time course and the significance of serum levels of pancreatic secretory enzymes.
Doppl WE; Weber HP; Temme H; Klör HU; Federlin K
Eur J Med Res; 1996 Mar; 1(6):303-11. PubMed ID: 9367944
[TBL] [Abstract][Full Text] [Related]
15. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
17. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
[TBL] [Abstract][Full Text] [Related]
18. The effect of ERCP on circulating pancreatic enzymes and pancreatic protease inhibitors.
Conn M; Goldenberg A; Concepcion L; Mandeli J
Am J Gastroenterol; 1991 Aug; 86(8):1011-4. PubMed ID: 1713406
[TBL] [Abstract][Full Text] [Related]
19. Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis.
Kemppainen E; Hedström J; Puolakkainen P; Halttunen J; Sainio V; Haapiainen R; Stenman UH
Endoscopy; 1997 May; 29(4):247-51. PubMed ID: 9255526
[TBL] [Abstract][Full Text] [Related]
20. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
